| Literature DB >> 35821469 |
Estefania Dibello1,2, Marcelo A Comini3, Diego Benítez4.
Abstract
This chapter introduces a simple and robust in vitro viability assay to screen bioactive small molecules (e.g., natural, synthetic) against the monomorphic and infective (bloodstream) form of Trypanosoma brucei brucei. The assay relies on a bioluminescent transgenic parasite harboring a genetically encoded copy of a thermostable redshifted firefly luciferase from Photinus pyralis.The major advantages of the assay are simplicity and cost efficiency, along with excellent quality parameters. The bioassay allows estimating parasite numbers and viability (and metabolic state) as a function of bioluminescence (BL) signal. Parasites are grown in the presence of the molecules of interest in a 96-well microplate, and 24 h later, BL is determined with a simple protocol lacking washing steps, using cost-efficient reagents with a reasonable readout time for high-throughput applications.Entities:
Keywords: Bioluminescence; D-Luciferin; Drug discovery; Redshifted firefly luciferase; Trypanosoma brucei
Mesh:
Substances:
Year: 2022 PMID: 35821469 DOI: 10.1007/978-1-0716-2453-1_11
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745